药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Clotiazepam
Anetumab ravtansine
Estradiol valerate may increase the thrombogenic activities of Anetumab ravtansine.
Clotiazepam
Gancotamab
Estradiol valerate may increase the thrombogenic activities of Gancotamab.
Clotiazepam
Setrusumab
Estradiol valerate may increase the thrombogenic activities of Setrusumab.
Clotiazepam
Camrelizumab
Estradiol valerate may increase the thrombogenic activities of Camrelizumab.
Clotiazepam
Risankizumab
Estradiol valerate may increase the thrombogenic activities of Risankizumab.
Clotiazepam
Cemiplimab
Estradiol valerate may increase the thrombogenic activities of Cemiplimab.
Clotiazepam
Lanadelumab
Estradiol valerate may increase the thrombogenic activities of Lanadelumab.
Clotiazepam
Lecanemab
Estradiol valerate may increase the thrombogenic activities of Lecanemab.
Clotiazepam
Fanolesomab
Estradiol valerate may increase the thrombogenic activities of Fanolesomab.
Clotiazepam
Galcanezumab
Estradiol valerate may increase the thrombogenic activities of Galcanezumab.
Clotiazepam
Fremanezumab
Estradiol valerate may increase the thrombogenic activities of Fremanezumab.
Clotiazepam
Eptinezumab
Estradiol valerate may increase the thrombogenic activities of Eptinezumab.
Clotiazepam
Erenumab
Estradiol valerate may increase the thrombogenic activities of Erenumab.
Clotiazepam
Burosumab
Estradiol valerate may increase the thrombogenic activities of Burosumab.
Clotiazepam
Tildrakizumab
Estradiol valerate may increase the thrombogenic activities of Tildrakizumab.
Clotiazepam
Besilesomab
Estradiol valerate may increase the thrombogenic activities of Besilesomab.
Clotiazepam
Sulesomab
Estradiol valerate may increase the thrombogenic activities of Sulesomab.
Clotiazepam
Emicizumab
Estradiol valerate may increase the thrombogenic activities of Emicizumab.
Clotiazepam
Human cytomegalovirus immune globulin
Estradiol valerate may increase the thrombogenic activities of Human cytomegalovirus immune globulin.
Clotiazepam
Nebacumab
Estradiol valerate may increase the thrombogenic activities of Nebacumab.